Previous close | 286.52 |
Open | 280.00 |
Bid | 273.37 x 100 |
Ask | 273.76 x 200 |
Day's range | 263.99 - 281.79 |
52-week range | 176.34 - 413.20 |
Volume | |
Avg. volume | 619,121 |
Market cap | 20.601B |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | 45.23 |
EPS (TTM) | 6.05 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 338.96 |
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.